Status:
SUSPENDED
Intravenous Ketamine for Pain Control During First Trimester Surgical Abortion
Lead Sponsor:
Dr. Marie Eve Sophie Bussiere-Cote
Conditions:
Abortion in First Trimester
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
A therapeutic abortion is one of the most common procedures performed in Canada, with approximately 100,000 occurring annually. 95% of induced abortions are done surgically, with just over two thirds ...
Detailed Description
Rationale: At present, the gold standard for pain control during first trimester abortion is the combination of a paracervical block with moderate intravenous (IV) sedation. Paracervical blocks are r...
Eligibility Criteria
Inclusion
- Confirmed first trimester pregnancy with an ultrasound showing a viable intrauterine pregnancy with a gestational age of less than 12 weeks since the last menstrual period
- Unwanted pregnancy and consented to undergo a first trimester surgical abortion
Exclusion
- Age \<18 years at the time of study enrollment
- Known allergy or sensitivity to any of the medications used in the study
- Any serious medical comorbidity that would make IV sedation contraindicated in an outpatient setting (ex. Heart disease, lung disease)
Key Trial Info
Start Date :
June 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
123 Patients enrolled
Trial Details
Trial ID
NCT03751423
Start Date
June 10 2019
End Date
December 31 2023
Last Update
September 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen's University
Kingston, Ontario, Canada, K7L2V7